Hepatitis D Virus Infection

Hepatitis D virus interferes with hepatitis B virus RNA production via interferon-dependent and -independent mechanisms

(2023) Julie Lucifora et al.   JOURNAL OF HEPATOLOGY

Delta hepatitis epidemiology and the global burden of disease

(2023) Tatyana Kushner   JOURNAL OF VIRAL HEPATITIS

Treatment of chronic hepatitis D with peginterferon lambda—the phase 2 LIMT-1 clinical trial

(2023) Ohad Etzion et al.   HEPATOLOGY

A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D

(2023) Heiner Wedemeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chronic hepatitis D—What is changing?

(2022) David Yardeni et al.   JOURNAL OF VIRAL HEPATITIS

Review article: emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus

(2022) Carla Usai et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread

(2022) Zhenfeng Zhang et al.   JOURNAL OF HEPATOLOGY

Liver Transplantation in Hepatitis B/Hepatitis D (Delta) Virus Coinfected Recipients

(2022) Silvia Martini et al.   TRANSPLANTATION

Low Performance of Hepatitis Delta Virus Testing Among Two National Cohorts of Chronic Hepatitis B Patients in the United States

(2022) Robert J. Wong et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies

(2022) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial

(2022) Heiner Wedemeyer et al.   LANCET INFECTIOUS DISEASES

Natural history of untreated HDV patients: always a progressive disease?

(2022) Habiba Kamal et al.   LIVER INTERNATIONAL

Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries

(2022) Amie Ceesay et al.   Microorganisms

Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update

(2022) Peter Ferenci et al.   Cells

The changing scenario of hepatitis D

(2021) Mario Rizzetto et al.   JOURNAL OF HEPATOLOGY

The hepatitis D virus in Italy. A vanishing infection, not yet a vanished disease

(2021) Gian Paolo Caviglia et al.   Journal of Advanced Research

Epidemiology estimates of hepatitis D in individuals co‐infected with human immunodeficiency virus and hepatitis B virus, 2002–2018: A systematic review and meta‐analysis

(2021) Dan‐Ting Shen et al.   JOURNAL OF VIRAL HEPATITIS

One‐quarter of chronic hepatitis D patients reach HDV‐RNA decline or undetectability during the natural course of the disease

(2021) Adriana Palom et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Endpoints and New Options for Treatment of Chronic Hepatitis D

(2021) Anna S. Lok et al.   HEPATOLOGY

Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study

(2021) Evelyn Stelzl et al.   JOURNAL OF CLINICAL VIROLOGY

Risk of hepatocellular carcinoma in hepatitis B and D virus co‐infected patients: A systematic review and meta‐analysis of longitudinal studies

(2021) Habiba Kamal et al.   JOURNAL OF VIRAL HEPATITIS

HDV-Like Viruses

(2021) Jimena Pérez-Vargas et al.   Viruses-Basel

A phase 2 dose‐finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis

(2021) Cihan Yurdaydin et al.   HEPATOLOGY

Hepatitis delta genotype 5 is associated with favourable disease outcome and better response to treatment compared to genotype 1

(2020) Michelle Spaan et al.   JOURNAL OF HEPATOLOGY

Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies

(2020) Dulce Alfaiate et al.   JOURNAL OF HEPATOLOGY

Future treatments for hepatitis delta virus infection

(2020) Tarik Asselah et al.   LIVER INTERNATIONAL

Long‐term study of hepatitis D infection at secondary care centers: the impact of viremia on liver‐related outcomes

(2020) Habiba Kamal et al.   HEPATOLOGY

Migratory flow and hepatitis delta infection in Italy: A new challenge at the beginning of the third millennium

(2020) Tommaso Stroffolini et al.   JOURNAL OF VIRAL HEPATITIS

Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis Delta

(2020) Dominique Roulot et al.   JOURNAL OF HEPATOLOGY

Ten‐year follow‐up of a randomized controlled clinical trial in chronic hepatitis delta

(2020) Anika Wranke et al.   JOURNAL OF VIRAL HEPATITIS

Infection by Hepatitis Delta Virus

(2020) John M. Taylor   Viruses-Basel

Hepatitis delta virus propagation enabled by hepatitis C virus—Scientifically intriguing, but is it relevant to clinical practice?

(2020) Lisa Sophie Pflüger et al.   JOURNAL OF VIRAL HEPATITIS

The medical impact of hepatitis D virus infection in Asia and Africa; time for a reappraisal

(2020) Mario Rizzetto et al.   LIVER INTERNATIONAL

Prevalence of Hepatitis B and Hepatitis D Virus Infections in the United States, 2011–2016

(2019) Eshan U Patel et al.   CLINICAL INFECTIOUS DISEASES

Enveloped viruses distinct from HBV induce dissemination of hepatitis D virus in vivo

(2019) Jimena Perez-Vargas et al.   Nature Communications

Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia

(2019) Adriana Palom et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

(2018) Norah A. Terrault et al.   HEPATOLOGY

Treating Chronic Hepatitis Delta: The Need for Surrogate Markers of Treatment Efficacy

(2018) Cihan Yurdaydin et al.   JOURNAL OF HEPATOLOGY

Genetic diversity and worldwide distribution of the deltavirus genus: A study of 2,152 clinical strains

(2017) Frédéric Le Gal et al.   HEPATOLOGY

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)

(2017) Anika Wranke et al.   LIVER INTERNATIONAL

First international external quality assessment for hepatitis delta virus RNA quantification in plasma

(2016) Frédéric Le Gal et al.   HEPATOLOGY

Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options

(2016) Florian A. Lempp et al.   Nature Reviews Gastroenterology & Hepatology

Pathogenesis by subviral agents: viroids and hepatitis delta virus

(2016) Ricardo Flores et al.   Current Opinion in Virology

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update

(2015) S. K. Sarin et al.   Hepatology International

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

(2015) Christopher Koh et al.   LANCET INFECTIOUS DISEASES

Envelope Proteins Derived from Naturally Integrated Hepatitis B Virus DNA Support Assembly and Release of Infectious Hepatitis Delta Virus Particles

(2014) N. Freitas et al.   JOURNAL OF VIROLOGY

Bats carry pathogenic hepadnaviruses antigenically related to hepatitis B virus and capable of infecting human hepatocytes

(2013) J. F. Drexler et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Clinical Features of Hepatitis D

(2012) Patrizia Farci et al.   SEMINARS IN LIVER DISEASE

Hepatitis Delta Virus Diagnosis

(2012) Antonella Olivero et al.   SEMINARS IN LIVER DISEASE